This paper delves into the key modulation techniques and demonstrates their simulation using LabVIEW, providing valuable ...

Allarity Therapeutics ( ($ALLR) ) has shared an update. On June 2, 2025, Allarity Therapeutics announced the enrollment of the first patient in ...

Results, presented simultaneously in oral presentation at ASCO 2025 and in peer-reviewed Gynecologic Oncology, suggest very meaningful survival effect of IMNN-001 in women HRP and HRD positive, ...

The trial is expected to generate significant clinical data by late summer 2026. Allarity plans to pursue multiple advantaged ...

Rion Aesthetics, an internationally recognized regenerative aesthetics company, today announced that the U.S. Food and Drug ...

By balancing supply and demand in real time, the facility not only enhances grid reliability but also supports the ...

Rion Aesthetics, an internationally recognized regenerative aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has allowed an Investigational New Drug (IND) ...

The presentation will feature the design and objectives of the Phase 1 study, which marks the first clinical application of ...

Home > Press release: Successful Development of Innovative and ...

Copper has many uses—in electrical wires, plumbing and even coins. With its abundance and relatively low price tag, copper ...

Therapeutics announced that the first patient has been enrolled in its new Phase 2 clinical trial protocol of stenoparib for the ...